AVR 0.00% $18.00 anteris technologies ltd

EACTS 2014, page-63

  1. 294 Posts.
    lightbulb Created with Sketch. 8
    Seems pasting that table in buggered up all the formatting, here it is again (hope it works this time):

    Column 1 Column 2 Column 3 Column 4
    0   Release date Current Quarter Year to Date
    1 June 2013 4C 30/07/2013 $2,064,000.00 $7,354,000.00
    2 September 2013 4C 31/10/2013 $2,198,000.00 $2,198,000.00
    3 First Cardiocel Sales to Europe 20/11/2013    
    4 December 2013 4C 31/01/2014 $1,950,000.00 $4,148,000.00
    5 Cardiocel cleared for sale in US 10/02/2014    
    6 March 2014 4C 24/04/2014 $1,700,000.00 $5,848,000.00
    7 Cardiocel sales update - First sales to the US 7/05/2014    
    8 Share purchase plan 12/05/2014    
    9 June 2014 4C 30/07/2014 $1,982,000.00 $7,830,000.00
    10 Admedus ships Cardiocel to US from new facility 14/08/2014    
    11 September 2014 4C 31/10/2014 ????? ?????
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.